Efficacy and safety of tislelizumab combined with bronchial arterial infusion (BAI) chemotherapy in potentially resectable stage IIIB non-small cell lung cancer(NSCLC): A prospective, single-arm phase II clinical study

Authors
Category Primary study
JournalImmuno-Oncology and Technology
Year 2024
This article has no abstract
Epistemonikos ID: ab7ecfad31faa07293c6e9a74b31efb2e7d9eb41
First added on: Feb 19, 2025